Lyme Disease Treatment and Vaccine

  • Print
  • Email
  • Favorite
  • Share
  • Newsletters

Nearly 50% of adult horses in areas of the northeastern United States are or have been infected with Borrelia burgdorferi, the causative agent of Lyme disease. Thomas Divers, DVM, Dipl. ACVIM, Dipl. ACVECC, and others at Cornell University recently completed research that confirmed the value of tetracycline treatment and efficacy of a recombinant outer-surface protein A (rOspA) vaccine

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners